Fosdesdenosine sipalabenamide is a phosphoramidate prodrug of the monophosphate form of cordycepin (3'-deoxyadenosine). After cellular uptake it is converted to 3'-deoxyadenosine triphosphate, which competes with ATP during transcription, inhibits RNA synthesis and induces apoptosis. It is studied in advanced cancer, lymphoma, solid tumors and melanoma.
Summary written with AI from the sources listed at the end of this page.
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.